Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemophilia a | D006467 | EFO_0007267 | D66 | — | 2 | 5 | 1 | 5 | 12 |
Von willebrand diseases | D014842 | EFO_0003910 | D68.0 | — | 1 | 1 | 2 | — | 3 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | — | — | 1 | — | 1 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | — | 1 | — | 1 |
Blood platelet disorders | D001791 | — | — | — | — | — | 1 | — | 1 |
Hemostatic disorders | D020141 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | — | 1 | — | — | — | 1 |
Sclerosis | D012598 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Antihemophilic factor pegylated (mw 20000) human sequence recombinant |
INN | rurioctocog alfa pegol |
Description | Antihemophilic factor, pegylated (mw 20000) human sequence recombinant is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Unknown |
Drug class | PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594584 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 5X3GF74R79 (ChemIDplus, GSRS) |